Original Research

Oral Contraceptives for Acne Treatment: US Dermatologists’ Knowledge, Comfort, and Prescribing Practices

Cutis. 2017 March;99(3):195-201

PDF Download

References

Kim GK, Michaels BB. Post-adolescent acne in women: more common and more clinical considerations. J Drugs Dermatol. 2012;11:708-713.
Arowojolu AO, Gallo MF, Lopez LM, et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. July 11, 2012:CD004425.
Koo EB, Petersen TD, Kimball AB. Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris. J Am Acad Dermatol. 2014;71:450-459.
Strauss JS, Krowchuk DP, Leyden JJ, et al; American Academy of Dermatology/American Academy of Dermatology Association. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56:651-663.
Harper JC. Should dermatologists prescribe hormonal contraceptives for acne? Dermatol Ther. 2009;22:452-457.
Landis ET, Levender MM, Davis SA, et al. Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey. J Dermatol Treat. 2012;23:272-277.
Lam C, Zaenglein AL. Contraceptive use in acne. Clin Dermatol. 2014;32:502-515.
Katsambas AD, Dessinioti C. Hormonal therapy for acne: why not as first line therapy? facts and controversies. Clin Dermatol. 2010;28:17-23.
Dragoman MV. The combined oral contraceptive pill—recent developments, risks and benefits. Best Pract Res Clin Obstet Gynaecol. 2014;28:825-834.
Thorneycroft IH, Gollnick H, Schellschmidt I. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment. Cutis. 2004;74:123-130.
Mansour D, Verhoeven C, Sommer W, et al. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen. Eur J Contracept Reproduct Health Care. 2011;16:430-443.
Wu CQ, Grandi SM, Filion KB, et al. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review. BJOG. 2013;120:801-810.
Ziller M, Rashed AN, Ziller V, et al. The prescribing of contraceptives for adolescents in German gynecologic practices in 2007 and 2011: a retrospective database analysis. J Pediatr Adolesc Gynecol. 2013;26:261-264.
Centers for Disease Control and Prevention. US medical eligibility criteria for contraceptive use, 2010. MMWR Recomm Rep. 2010;59(RR-4):1-86.
United States Census Bureau. Census Regions and Divisions of the United States. New York, NY: United States Department of Commerce; 2010.
Resident Population Data—Population Density, 1910 to 2010. U.S. Census Bureau; 2012. http ://www.census.gov/2010census/data/apportionment-dens-text.php. Accessed January 9, 2017.
Reschovsky A, Zahner SJ. Forecasting the revenues of local public health departments in the shadows of the “Great Recession.” J Public Health Manag Pract. 2016;22:120-128.
Klipping C, Duijkers I, Fortier MP, et al. Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study. J Fam Plann Reprod Health Care. 2012;38:73-83.

References

Kim GK, Michaels BB. Post-adolescent acne in women: more common and more clinical considerations. J Drugs Dermatol. 2012;11:708-713.
Arowojolu AO, Gallo MF, Lopez LM, et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. July 11, 2012:CD004425.
Koo EB, Petersen TD, Kimball AB. Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris. J Am Acad Dermatol. 2014;71:450-459.
Strauss JS, Krowchuk DP, Leyden JJ, et al; American Academy of Dermatology/American Academy of Dermatology Association. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56:651-663.
Harper JC. Should dermatologists prescribe hormonal contraceptives for acne? Dermatol Ther. 2009;22:452-457.
Landis ET, Levender MM, Davis SA, et al. Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey. J Dermatol Treat. 2012;23:272-277.
Lam C, Zaenglein AL. Contraceptive use in acne. Clin Dermatol. 2014;32:502-515.
Katsambas AD, Dessinioti C. Hormonal therapy for acne: why not as first line therapy? facts and controversies. Clin Dermatol. 2010;28:17-23.
Dragoman MV. The combined oral contraceptive pill—recent developments, risks and benefits. Best Pract Res Clin Obstet Gynaecol. 2014;28:825-834.
Thorneycroft IH, Gollnick H, Schellschmidt I. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment. Cutis. 2004;74:123-130.
Mansour D, Verhoeven C, Sommer W, et al. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen. Eur J Contracept Reproduct Health Care. 2011;16:430-443.
Wu CQ, Grandi SM, Filion KB, et al. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review. BJOG. 2013;120:801-810.
Ziller M, Rashed AN, Ziller V, et al. The prescribing of contraceptives for adolescents in German gynecologic practices in 2007 and 2011: a retrospective database analysis. J Pediatr Adolesc Gynecol. 2013;26:261-264.
Centers for Disease Control and Prevention. US medical eligibility criteria for contraceptive use, 2010. MMWR Recomm Rep. 2010;59(RR-4):1-86.
United States Census Bureau. Census Regions and Divisions of the United States. New York, NY: United States Department of Commerce; 2010.
Resident Population Data—Population Density, 1910 to 2010. U.S. Census Bureau; 2012. http ://www.census.gov/2010census/data/apportionment-dens-text.php. Accessed January 9, 2017.
Reschovsky A, Zahner SJ. Forecasting the revenues of local public health departments in the shadows of the “Great Recession.” J Public Health Manag Pract. 2016;22:120-128.
Klipping C, Duijkers I, Fortier MP, et al. Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study. J Fam Plann Reprod Health Care. 2012;38:73-83.

Oral Contraceptives for Acne Treatment: US Dermatologists’ Knowledge, Comfort, and Prescribing Practices

References

Results

Demographics

Pages

Recommended Reading

Related Articles

Commentary

High-Value, Cost-Conscious Evaluation for PCOS: Which Tests Should Be Routinely Ordered in Acne Patients?

Original Research

Impact of Acne Vulgaris on Quality of Life and Self-esteem

Blog

Acne and Antiaging: Is There a Connection?